Bio-Rad Laboratories Inc (BIO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bio-Rad Laboratories Inc (BIO) has a cash flow conversion efficiency ratio of 0.022x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($164.90 Million) by net assets ($7.45 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bio-Rad Laboratories Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Bio-Rad Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Bio-Rad Laboratories Inc debt and liabilities for a breakdown of total debt and financial obligations.
Bio-Rad Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio-Rad Laboratories Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Avanza Bank Holding AB (publ)
ST:AZA
|
1.029x |
|
United Integrated Services Co Ltd
TW:2404
|
0.448x |
|
MGIC Investment Corp
NYSE:MTG
|
0.045x |
|
Grupo Comercial Chedraui S.A.B. de C.V
MX:CHDRAUIB
|
0.110x |
|
Kingnet Network Co Ltd
SHE:002517
|
0.057x |
|
News Corp B
NASDAQ:NWS
|
0.024x |
|
Caitong Securities Co Ltd
SHG:601108
|
0.025x |
|
Yinyi Real Estate Co Ltd
SHE:000981
|
0.011x |
Annual Cash Flow Conversion Efficiency for Bio-Rad Laboratories Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of Bio-Rad Laboratories Inc from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see Bio-Rad Laboratories Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.45 Billion | $532.20 Million | 0.071x | +3.04% |
| 2024-12-31 | $6.57 Billion | $455.20 Million | 0.069x | +61.54% |
| 2023-12-31 | $8.74 Billion | $374.94 Million | 0.043x | +112.11% |
| 2022-12-31 | $9.62 Billion | $194.45 Million | 0.020x | -57.85% |
| 2021-12-31 | $13.69 Billion | $656.52 Million | 0.048x | -18.98% |
| 2020-12-31 | $9.88 Billion | $584.97 Million | 0.059x | -25.58% |
| 2019-12-31 | $5.76 Billion | $457.90 Million | 0.080x | +12.04% |
| 2018-12-31 | $4.02 Billion | $285.49 Million | 0.071x | +99.82% |
| 2017-12-31 | $2.93 Billion | $104.14 Million | 0.036x | -57.58% |
| 2016-12-31 | $2.58 Billion | $216.07 Million | 0.084x | +12.04% |
| 2015-12-31 | $2.49 Billion | $186.21 Million | 0.075x | -40.22% |
| 2014-12-31 | $2.19 Billion | $273.31 Million | 0.125x | +61.71% |
| 2013-12-31 | $2.19 Billion | $169.14 Million | 0.077x | -41.50% |
| 2012-12-31 | $2.02 Billion | $266.48 Million | 0.132x | -12.22% |
| 2011-12-31 | $1.74 Billion | $262.74 Million | 0.151x | +2.71% |
| 2010-12-31 | $1.54 Billion | $225.91 Million | 0.147x | -42.29% |
| 2009-12-31 | $1.28 Billion | $325.07 Million | 0.254x | +42.17% |
| 2008-12-31 | $1.07 Billion | $191.37 Million | 0.179x | -9.34% |
| 2007-12-31 | $971.69 Million | $191.58 Million | 0.197x | +36.67% |
| 2006-12-31 | $819.54 Million | $118.23 Million | 0.144x | -12.34% |
| 2005-12-31 | $657.97 Million | $108.28 Million | 0.165x | -20.20% |
| 2004-12-31 | $596.89 Million | $123.09 Million | 0.206x | -19.89% |
| 2003-12-31 | $495.81 Million | $127.64 Million | 0.257x | -6.75% |
| 2002-12-31 | $383.09 Million | $105.76 Million | 0.276x | -21.23% |
| 2001-12-31 | $283.88 Million | $99.50 Million | 0.350x | +253.59% |
| 2000-12-31 | $244.62 Million | $24.25 Million | 0.099x | -51.52% |
| 1999-12-31 | $220.10 Million | $45.00 Million | 0.204x | +60.49% |
| 1998-12-31 | $214.30 Million | $27.30 Million | 0.127x | +18.76% |
| 1997-12-31 | $196.70 Million | $21.10 Million | 0.107x | -40.71% |
| 1996-12-31 | $183.50 Million | $33.20 Million | 0.181x | -25.59% |
| 1995-12-31 | $157.10 Million | $38.20 Million | 0.243x | -34.65% |
| 1994-12-31 | $129.80 Million | $48.30 Million | 0.372x | +82.42% |
| 1993-12-31 | $110.30 Million | $22.50 Million | 0.204x | +446.18% |
| 1992-12-31 | $107.10 Million | $4.00 Million | 0.037x | -17.29% |
| 1991-12-31 | $90.80 Million | $4.10 Million | 0.045x | -69.74% |
| 1990-12-31 | $81.10 Million | $12.10 Million | 0.149x | +4.90% |
| 1989-12-31 | $68.90 Million | $9.80 Million | 0.142x | -- |
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more